Egypt: Premium Diagnostics to establish holding company, conduct IPO by H2 of 2024

Mohamed Abd El Ghany

Mahmoud Lashin, the Chairperson of Premium Diagnostics, said that this step will be completed in the second half of the current year 2024

Fatma Salah, Daily News Egypt

January 10, 2024

PHOTO

Egypt - Premium Diagnostics hired an English company as a financial advisor to establish a holding company for its offices in the United States, Saudi Arabia, the United Arab Emirates, and Egypt, to offer its shares on the stock exchange in the UAE or Saudi Arabia. The company plans to raise its capital from $14m to $24m to finance its expansion plans for the current year 2024.

Mahmoud Lashin, the Chairperson of Premium Diagnostics, said that this step will be completed in the second half of the current year 2024.

Premium Diagnostics has four offices in Egypt, Saudi Arabia, the United States, and the UAE. The group aims to become the largest provider of medical laboratory services in the Middle East and to trade laboratory supplies in these countries through strong partnerships in the targeted expansion regions.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.